Strides Pharma Science announced that its formulation facility at Alathur (Chennai), India underwent a USFDA inspection which concluded with gZero 483 observationsh. This is the second consecutive Zero 483 inspection for the site. The current inspection was a Pre]Approval Inspection for sustained release class of drugs which is a new dosage format for the facility and is one of the focus areas for the
company in the global markets.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
